MediciNova Receives Notice of Patent Allowance for Method of Treating Acute … – NASDAQ

MediciNova Receives Notice of Patent Allowance for Method of Treating Acute
NASDAQ
SAN DIEGO, Dec. 9, 2012 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company that is publicly traded on the NASDAQ Global Market (Nasdaq:MNOV) and the Jasdaq Market of the Osaka Securities Exchange (Code Number: 4875),

and more »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.